Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Vaxchora Market Report 2025

Vaxchora Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Clinical Indication (Prevention Of Cholera, Prevention Of Gastrointestinal Infections Caused By Vibrio Cholerae), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Travel Clinics), By End User (Adult, Pediatric, Geriatric)

Vaxchora Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Vaxchora Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Vaxchora Market Definition

Vaxchora is a vaccine used to prevent cholera, an infectious disease caused by the bacterium Vibrio cholerae. It is specifically approved for use in individuals aged 2 years and older traveling to areas where cholera is common. Vaxchora is recommended for adults aged 18 to 64 who are planning to visit regions where cholera is prevalent. The vaccine comes as a single-dose liquid, taken 10 days before potential contact with the bacteria.

The main clinical indications in the vaxchora market are prevention of cholera and prevention of gastrointestinal infections caused by vibrio cholerae. Prevention of Cholera refers to the process of avoiding the spread of vibrio cholerae, the bacteria responsible for causing cholera, through vaccination, sanitation, and safe water practices. Vaxchora is an oral vaccine used to prevent cholera by stimulating immunity against vibrio cholerae in individuals traveling to endemic areas. The various distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and travel pharmacies, and several end users including adult, pediatric, and geriatric.

Vaxchora Market Segmentation

The vaxchora market covered in this report is segmented –

1) By Clinical Indication: Prevention Of Cholera; Prevention Of Gastrointestinal Infections Caused By Vibrio Cholerae

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Travel Clinics

3) By End User: Adult; Pediatric; Geriatric

Vaxchora Market Size and growth rate 2025 to 2029: Graph

Vaxchora Market Size 2025 And Growth Rate

The vaxchora market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growth in prevalence of waterborne diseases, rise in consumer preference for needle-free vaccination, rise in investments in global health initiatives, growth in demand for cholera vaccines, and rise in urbanization and poor sanitation.

Vaxchora Market Growth Forecast

The vaxchora market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising cholera outbreaks cases, increasing international travel to cholera-endemic regions, rising awareness of cholera risks among travelers, increasing funding for cholera vaccination campaigns, and growing medical tourism industry. Major trends in the forecast period include advancements in vaccine formulation, advancements in oral vaccine, advancements in microbiology and immunology research, and integration of AI for cholera outbreak prediction models.

Book your 30 minutes free consultation with our research experts

Contact Us

Vaxchora Market Driver: Impact Of Rising Cholera Incidence On Vaccine Demand

The rise in the incidence of cholera cases is expected to drive the growth of the vaxchora market going forward. Cholera is an infection caused by the vibrio cholerae bacterium, leading to severe diarrhea and dehydration from contaminated water or food. Cholera cases are rising due to factors such as inadequate sanitation, poor access to clean water, climate change, and increased population mobility to cholera-endemic regions. Vaxchora prevents cholera by stimulating the immune system to produce antibodies against Vibrio cholerae serogroup O1, reducing the risk of severe diarrhea and dehydration caused by cholera infection. For instance, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization for public health, in 2023, cholera cases rose by 13%, with deaths increasing by a significant 71% compared to 2022, resulting in over 4,000 preventable deaths. The disease spread to 45 countries, up from 44 in 2022 and 35 in 2021. Therefore, the rise in the incidence of cholera cases is driving the growth of the vaxchora market.

Global Vaxchora Market Major Players

Major companies operating in the vaxchora market are Bavarian Nordic A/S

Global Vaxchora Market Trend: Expanding Regional Approvals To Enhance Cholera Prevention

The key trend in the vaxchora market is expanded vaccination regional approvals to increase accessibility and cater to the growing demand for cholera prevention in endemic and high-risk areas. Expanded regional approvals help improve public health outcomes through broader immunization coverage and address the ever increasing global need for effective cholera prevention solutions. For example, in September 2024, Bavarian Nordic, a Denmark-based biotechnology company, announced the commercial availability of Vaxchora, the only single-dose oral vaccine approved in Canada to protect against cholera, a sudden and severe intestinal infection marked by acute watery diarrhea. The vaccine is delivered as a single oral dose and protects within 10 days.

Vaxchora Market Merger And Acquisition: Bavarian Nordic Strengthens Travel Vaccine Portfolio With Acquisition

In May 2023, Bavarian Nordic A/S, a Denmark-based biotechnology company, acquired travel vaccine portfolio from Emergent BioSolutions for $270 million. The acquisition includes two marketed vaccines, Vivotif for typhoid fever and Vaxchora for cholera, and a promising Phase III candidate for chikungunya, addressing critical unmet medical needs. This strategic move aims to strengthen Bavarian Nordic's position in the travel vaccine market while enhancing its research and development capabilities. Emergent BioSolutions is a US-based biotech company developing vaccines, including Vaxchora.

Regional Analysis For The Global Vaxchora Market

North America was the largest region in the vaxchora market in 2024. The regions covered in the vaxchora market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vaxchora market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Vaxchora Market?

The vaxchora market consists of sales of oral cholera vaccines, vaccine administration supplies, and cold chain equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Vaxchora Industry?

The vaxchora market research report is one of a series of new reports from The Business Research Company that provides vaxchora market statistics, including the vaxchora industry's global market size, regional shares, competitors with a vaxchora market share, detailed vaxchora market segments, market trends and opportunities, and any further data you may need to thrive in the vaxchora industry. This vaxchora market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Vaxchora Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The vaxchora market covered in this report is segmented –
1) By Clinical Indication: Prevention Of Cholera; Prevention Of Gastrointestinal Infections Caused By Vibrio Cholerae
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Travel Clinics
3) By End User: Adult; Pediatric; Geriatric
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Bavarian Nordic A/S
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Vaxchora Market Characteristics

    3. Vaxchora Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Vaxchora Market Trends And Strategies

    5. Vaxchora Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Vaxchora Growth Analysis And Strategic Analysis Framework

    6.1. Global Vaxchora PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Vaxchora Market Growth Rate Analysis

    6.4. Global Vaxchora Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Vaxchora Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Vaxchora Total Addressable Market (TAM)

    7. Global Vaxchora Pricing Analysis & Forecasts

    8. Vaxchora Market Segmentation

    8.1. Global Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Prevention Of Cholera

    Prevention Of Gastrointestinal Infections Caused By Vibrio Cholerae

    8.2. Global Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    Travel Clinics

    8.3. Global Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Adult

    Pediatric

    Geriatric

    9. Global Vaxchora Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Vaxchora Market Regional And Country Analysis

    10.1. Global Vaxchora Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Vaxchora Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Vaxchora Market

    11.1. Asia-Pacific Vaxchora Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Vaxchora Market

    12.1. China Vaxchora Market Overview

    12.2. China Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Vaxchora Market

    13.1. India Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Vaxchora Market

    14.1. Japan Vaxchora Market Overview

    14.2. Japan Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Vaxchora Market

    15.1. Australia Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Vaxchora Market

    16.1. South Korea Vaxchora Market Overview

    16.2. South Korea Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Vaxchora Market

    17.1. Western Europe Vaxchora Market Overview

    17.2. Western Europe Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Vaxchora Market

    18.1. UK Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Vaxchora Market

    19.1. Germany Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Vaxchora Market

    20.1. France Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Vaxchora Market

    21.1. Eastern Europe Vaxchora Market Overview

    21.2. Eastern Europe Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Vaxchora Market

    22.1. North America Vaxchora Market Overview

    22.2. North America Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Vaxchora Market

    23.1. USA Vaxchora Market Overview

    23.2. USA Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Vaxchora Market

    24.1. Canada Vaxchora Market Overview

    24.2. Canada Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Vaxchora Market

    25.1. South America Vaxchora Market Overview

    25.2. South America Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Vaxchora Market

    26.1. Middle East Vaxchora Market Overview

    26.2. Middle East Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Vaxchora Market

    27.1. Africa Vaxchora Market Overview

    27.2. Africa Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Vaxchora Market Competitive Landscape And Company Profiles

    28.1. Vaxchora Market Competitive Landscape

    28.2. Vaxchora Market Company Profiles

    28.2.1. Bavarian Nordic A/S Overview, Products and Services, Strategy and Financial Analysis

    29. Global Vaxchora Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Vaxchora Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Vaxchora Market

    32. Recent Developments In The Vaxchora Market

    33. Vaxchora Market High Potential Countries, Segments and Strategies

    33.1 Vaxchora Market In 2029 - Countries Offering Most New Opportunities

    33.2 Vaxchora Market In 2029 - Segments Offering Most New Opportunities

    33.3 Vaxchora Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Vaxchora Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Vaxchora Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Bavarian Nordic A/S Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Vaxchora Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Vaxchora Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Vaxchora Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Vaxchora Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Vaxchora Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Bavarian Nordic A/S Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Influenza Vaccines Global Market Report 2025 – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric, Adult), By Distribution Channel (Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pneumococcal Vaccine Global Market Report 2025 – By Product Type (Prevnar 13, Synflorix, Pneumovax23, Other Products), By Route of Administration (Intravenous, Intramuscular, Subcutaneous), By Distribution Channel (Pharmacies, Community Clinics, Public Health Agencies, Other Distribution Channels), By End User (Pediatrics, Adults) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Human Papillomavirus (HPV) Vaccine Global Market Report 2025 – By Type (Tetravalent, Nonavalent, Bivalent), By Disease Indication (Cervical Cancer, Anal Cancer, Vulvar And Vaginal Cancer, Penile Cancer, Oropharyngeal Cancer, Other Indications), By Distribution Channel (Hospital And Retail Pharmacies, Government Suppliers, Other Channels), By Industry Vertical (Public And Private Alliance, Government Entities, Physicians, Other Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plant-Based Vaccines Global Market Report 2025 – By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types), By Source (Tobacco Plant, Maize, Potato, Other Sources), By Application (Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Vaccine Contract Manufacturing Global Market Report 2025 – By Service Type (Fill-Finish, Bulk Product), By Vaccine Type (Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines), By Process (Downstream, Upstream), By Scale Of Operation (Preclinical, Clinical, Commercial), By End-Use (Human Use, Veterinary) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Respiratory Disease Vaccine Global Market Report 2025 – By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections), By Age (Infant, Adolescent, Adult), By End-User (Clinic, Hospital, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Inactivated Vaccines Global Market Report 2025 – By Type (Viral Vaccine, Bacterial Vaccine), By Method Of Inactivation (Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pertussis Vaccine Global Market Report 2025 – By Product Type (DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine), By Vaccine Type (Whole-Cell Vaccine, Acellular Vaccine), By Application (Children, Adults, Infants), By End-User (Vaccination Centers, Hospitals, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Vaxchora market?

Vaxchora is a vaccine used to prevent cholera, an infectious disease caused by the bacterium Vibrio cholerae. It is specifically approved for use in individuals aged 2 years and older traveling to areas where cholera is common. Vaxchora is recommended for adults aged 18 to 64 who are planning to visit regions where cholera is prevalent. The vaccine comes as a single-dose liquid, taken 10 days before potential contact with the bacteria. For further insights on the Vaxchora market, request a sample here

How will the Vaxchora market drivers and restraints affect the market dynamics? What forces will shape the Vaxchora industry going forward?

The Vaxchora market major growth driver - Impact Of Rising Cholera Incidence On Vaccine Demand. For further insights on the Vaxchora market, request a sample here

What is the forecast market size or the forecast market value of the Vaxchora market?

The Vaxchora market size has grown strongly in recent years. The vaxchora market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growth in prevalence of waterborne diseases, rise in consumer preference for needle-free vaccination, rise in investments in global health initiatives, growth in demand for cholera vaccines, and rise in urbanization and poor sanitation. The vaxchora market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising cholera outbreaks cases, increasing international travel to cholera-endemic regions, rising awareness of cholera risks among travelers, increasing funding for cholera vaccination campaigns, and growing medical tourism industry. Major trends in the forecast period include advancements in vaccine formulation, advancements in oral vaccine, advancements in microbiology and immunology research, and integration of AI for cholera outbreak prediction models. For further insights on the Vaxchora market, request a sample here

How is the Vaxchora market segmented?

The vaxchora market covered in this report is segmented –
1) By Clinical Indication: Prevention Of Cholera; Prevention Of Gastrointestinal Infections Caused By Vibrio Cholerae
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Travel Clinics
3) By End User: Adult; Pediatric; Geriatric For further insights on the Vaxchora market, request a sample here

Which region has the largest share of the Vaxchora market? What are the other regions covered in the report?

North America was the largest region in the vaxchora market in 2024. The regions covered in the vaxchora market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Vaxchora market, request a sample here.

Who are the major players in the Vaxchora market?

Major companies operating in the vaxchora market are Bavarian Nordic A/S . For further insights on the Vaxchora market, request a sample here.

What are the key trends in the Vaxchora market?

Major trends in the Vaxchora market include Expanding Regional Approvals To Enhance Cholera Prevention. For further insights on the Vaxchora market, request a sample here.

What are the major opportunities in the Vaxchora market? What are the strategies for the Vaxchora market?

For detailed insights on the major opportunities and strategies in the Vaxchora market, request a sample here.

How does the Vaxchora market relate to the overall economy and other similar markets?

For detailed insights on Vaxchora's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Vaxchora industry?

For detailed insights on the mergers and acquisitions in the Vaxchora industry, request a sample here.

What are the key dynamics influencing the Vaxchora market growth? SWOT analysis of the Vaxchora market.

For detailed insights on the key dynamics influencing the Vaxchora market growth and SWOT analysis of the Vaxchora industry, request a sample here.